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risk stratiﬁcation in patients with type 1 Brugada electrocardiographic
(ECG) pattern have considered a combined end point constituted by
implantable cardioverter-deﬁbrillator–recorded fast ventricular
arrhythmias (ICD-FVA) and sudden death (SD) in patients without ICD.
OBJECTIVE As ICD-FVA are only a surrogate of SD, we tried to focus
on the prognostic value of classical risk factors by separating
patients with ICD-FVA from those without ICD who suffered SD.
METHODS We made a cumulative analysis of the largest available
studies. Studies were selected in which the incidence of FVA and SD
could be determined in patients with and without ICD separately. In
addition, we tried to analyze the prognostic value of risk factors in
patients with and without ICD separately.
RESULTS A total of 2176 patients were recruited from 5 studies,
about one-third of whom had an ICD and two-thirds did not. Event
rates per 1000 patient-years of follow-up were 31.3 (25–39) and 6.5
(4–10) in patients with and without ICD, respectively (P o .001).
When considering FVA in patients with ICD, each single risk factorDr Stefano is employed by Medtronic. Address reprint requests and
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displayed limited clinical value, mainly owing to its low speciﬁcity
(21%–61%) and low positive predictive value (9%–15%).
CONCLUSIONS In patients with type 1 Brugada ECG pattern, most
arrhythmic events occur in patients with an ICD while SD is rare in
patients without an ICD. While we have an acceptable ability to
predict ICD-FVA, we have insufﬁcient data to predict SD.
KEYWORDS Brugada syndrome; Ventricular arrhythmias; Risk
stratiﬁcation; Sudden death; Implantable cardioverter-deﬁbrillator
ABBREVIATIONS ECG ¼ electrocardiogram/electrocardiographic;
þEPS ¼ positive electrophysiologic study; EPS ¼ negative
electrophysiologic study; ICD ¼ implantable cardioverter-
deﬁbrillator; ICD-FVA ¼ implantable cardioverter-deﬁbrillator–
recorded fast ventricular arrhythmias; PPV ¼ positive predictive
value; NPV ¼ negative predictive value; SD ¼ sudden death
(Heart Rhythm 2014;11:252–258) 2014 Heart Rhythm Society.I
Open access under CC BY-NC-ND license.Introduction
Patients with type 1 Brugada electrocardiographic (ECG)
pattern may suffer malignant arrhythmias and sudden death
(SD). The real incidence of sudden SD in patients with type 1
Brugada ECG pattern is uncertain, as is risk stratiﬁcation in
these patients. Indeed, all published prospective studies1–16
are registry-based population studies. There have been no
randomized studies allocating patients with risk factors to an
implantable cardioverter-deﬁbrillator (ICD) or no-ICD
groups. Furthermore, all studies have evaluated a combined
end point constituted by implantable cardioverter-deﬁbrilla-
tor–recorded fast ventricular arrhythmias (ICD-FVA) andSD in patients without ICD. Finally, as ICD-FVA and SD
have a low incidence, most studies1–8,10–16 have involved a
relatively low number of cases.
In order to collect a large population, we performed a
cumulative analysis of the largest published studies in
which patients with an ICD could be separated from those
without an ICD. Our purpose was to establish the incidence
of events in patients with and without an ICD, respectively.
Furthermore, we tried to evaluate the prognostic value of
classical risk factors with respect to ICD-FVA and to SD
separately.Methods
Study selection
We ﬁrst conducted a literature search by means of the
PubMed database in order to identify articles publishedhttp://dx.doi.org/10.1016/j.hrthm.2013.10.039
253Delise et al Sudden Death in Brugada Syndrome: A Cumulative Analysisbetween 2003 and 2012 that addressed the problem of the
prognostic stratiﬁcation of patients with type 1 Brugada ECG
pattern without previous cardiac arrest. Study selection was
ﬁrst based on the possibility to compare event rates
(incidence of ICD-FVA and SD) in patients with and without
an ICD. Furthermore, articles were selected when they had a
prospective design and included more than 150 patients. The
arbitrary choice of a cutoff of 150 patients was made in order
to exclude small studies, which could be affected by a
selection bias.
A further requirement was the possibility of establishing
the prevalence of classical risk factors (spontaneous type 1
ECG pattern, familial juvenile SD, syncope, and þEPS) in
patients with and without an ICD and their prognostic value
with respect to the incidence of ICD-FVA and SD in patients
with and without ICD, respectively.
On the basis of this research, we selected 6 large studies
(Table 1).1,2,10–13 Two other studies8,9 that initially did not
fulﬁll all inclusion criteria were added because authors send
us their raw data that were not available in their original
published articles.
Finally, in order to gather more data on patients with ICD,
2 further studies by Sacher et al17 and Sarkozy et al18 were
selected that analyzed only patients with ICD in detail
(Table 2). The article by Sarkozy was admitted, although it
referred to only 47 patients.
The homogeneity of the available studies was tested by
using a heterogeneity test. In addition, the Begg test was used
to evaluate any predominant effect.Table 1 Features of the largest studies published between 2003 and 2
Study
No. of
patients
Sex:
males
Type 1 ECG
pattern
Familial
juvenile SD Syncope þ
Brugada
et al4
547 408 71% 55% 23% 4
Eckardt
et al7
188 130 59% 30% 35% 4
Takagi
et al8
155 145 86% 10% 37% 7
Kamakura
et al9
200 190 69% 13% 23% 6
Giustetto
et al10
161 138 – – 36% 3
Probst
et al11
967 690 45% – 32% 4
Delise
et al12
320 258 54% 29% 34% 3
Priori
et al13
308 247 56% – 21% 4
Min-max
(%)
155–967 130–690 45–71 10–55 21–37 3
In the studies by Eckardt et al,7 Probst et al,11 and Giustetto et al,10 we exclude
no. of patient refer only to patients symptomatic for syncope or asymptomatic.
percentage of patients with an ICD, and the mean duration of follow-up are reporte
events.
ECG ¼ electrocardiographic; þEPS ¼ positive electropysiologic study; ICD ¼ im
recorded by implantable cardioverter-deﬁbrillator; SD (no ICD) ¼ sudden death in
*Including nonsustained ventricular tachycardia.Statistical analysis
When performing cumulative analyses, we excluded any
studies that also had been part of multicenter investigations
in order to avoid the double counting of patients. Event rates
(ICD-FVA and SD) were expressed per 1000 patient-years of
follow-up, with 95% conﬁdence intervals. Follow-up dura-
tions that were expressed as median values were changed to
means and variances by using the method described by Hozo
et al.19
The cumulative analysis of homogeneous studies was
done by calculating the sensitivity, speciﬁcity, positive
predictive value (PPV), and negative predictive value
(NPV) of risk factors, expressed as both percentages and
proportions. When considering each risk factor (eg, sponta-
neous type 1 ECG pattern), we classiﬁed the presence and
absence of this risk factor in patients with events as true
positive and false negative, respectively. Conversely, in
patients without events, the presence and absence of this
risk factor was classiﬁed as false positive and true negative,
respectively.
All analyses were performed by means of the StataSE
12.0 statistical software (StataCorp, College Station, TX).
Two sample-proportion tests were used to calculate statis-
tical differences between group percentages. Event rates
were compared between groups by means of incidence rate
(incidence density or person-time) data. In all statistical tests,
a value of P o .05 was considered statistically signiﬁcant
(when not speciﬁed, the P value should be considered
2-tailed).012
EPS
ICD
implantation
Mean
follow-up
(mo)
Total
events ICD-FVA
SD
(no ICD)
0% 32% 36 8.2% 5.3% 2.9%
1% 47% 26–39 2.7% 2.7% 0%
9%* 50% 39 2.2% 1.5% 0.7%
3% 35% 48 2% 1.5% 0.5%
4% 31% 30 3.7% 3% 0.7%
1% 40% 32.5 3% 2.3% 0.7%
9% 32% 40 5.3% 4.3% 1%
1% 45% 36 4.6% 4.6% 0%
4–79 31–50 26–40 2–8.2 1.5–5.3 0–2.9
d those patients who had a history of previous cardiac arrest. Therefore, the
The demographic characteristics and the prevalence of main risk factors,
d, as are the incidence of FVA interrupted by ICD, of SD and the sum of these
plantable cardioverter-deﬁbrillator; ICD-FVA ¼ fast ventricular arrhythmias
patients without implantable cardioverter-deﬁbrillator.
Table 2 Prevalence of risk factors in patients without previous cardiac arrest who underwent ICD implantation
Study
No. of
patients
Type 1 ECG
pattern Familial SD Syncope
þEPS/EPS
performed Follow-up (mo)
No. of events
(ICD-FVA)*
Sarkozy et al14 47 62% (29) 55% (26) 55% (26) 83% (38/46) Median 47
(IQR 4.5–156)
7 (7)
Sacher et al17 202 61% (124) 42% (85) 35% (70) 82% (153/187) Mean 38  27 14 (14)
Kamakura et al9 70 66% (44) 23% (16) 46% (32) 87% (58/67) Mean 50  13 3 (3)
Delise et al12 110 74% (82) 38% (42) 58% (64) 85% (90/106) Median 40
(IQR 20–67)
14 (10)
Priori et al13 137 – – – 72% (98/137) Mean 36  8 13 (13)
Total no. of
cases
566 279/429 (65%) 169/429 (39%) 192/429 (45%) 437/543 (80%) 51 (44)
ECG ¼ electrocardiographic; þEPS ¼ positive electropysiologic study; ICD ¼ implantable cardioverter-deﬁbrillator; ICD-FVA ¼ implantable cardioverter-
deﬁbrillator–recorded fast ventricular arrhythmias; IQR ¼ interquartile range; SD ¼ sudden death.
*The numbers in brackets refer to patients who had undergone EPS.
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We asked all authors of the included studies to check their
respective data in our text and tables and, if possible, to
provide further data. The authors found only minimal errors
in our analysis of data pooled from their original articles. All
errors were corrected.
The original articles by Eckardt et al,7 Takagi et al,8
Kamakura et al,9 Giustetto et al,10 and Probst et al,11 also
included patients with previous cardiac arrest. In all these
studies, our analysis was limited to patients who were
symptomatic for syncope or asymptomatic.
In the original study by Sacher et al,17 18 of 514 patients
had a history of previous cardiac arrest. These 18 patients
could not be excluded from the analysis of sensitivity,
speciﬁcity, PPV, and NPV of classical risk factors because,
in the original article, data from patients with previous
cardiac arrest were pooled with those of patients who only
had syncope or were asymptomatic. This problem was
solved by the authors, who sent us original data that excluded
patients with previous cardiac arrest.
In the original article by Brugada et al,4 the mean follow-
up reported was 24 32 months. When these authors sent us
their original data, they reported an updated follow-up of
36  31 months.Table 3 Cumulative analysis of studies in which events were compared
Study No. of patients Follow-up (mo)
Brugada et al4 547 Mean 36  31
Kamakura et al9 200 Mean 48  15
Probst et al11 967 Median 32 (IQR 14–54)
Delise et al12 154 Median 40 (IQR 20–67)
Priori et al13 308 Mean 36  8
Total 2176
The study by Eckardt et al7 was excluded from this analysis because some patien
Giustetto et al10 was also excluded because some patients were also included in t
*Finally, in the multicenter article published by our group12 in 2011, 166 cases
et al.11 Those patients from Giustetto et al10 who had taken part in the study by P
present analysis included only 154 cases instead of the 320 cases in our original
ICD ¼ implantable cardioverter-deﬁbrillator; ICD-FVA ¼ fast ventricular arrhyth
range; SD (no ICD) ¼ sudden death in patients without implantable cardioverter-In the multicenter study published by our group in
2011,12 a number of cases provided by Giustetto
et al10 had previously been included in the article by Probst
et al.11
Therefore, when we performed a cumulative analysis of
both our article12 and that of Probst et al11 (Table 2) to avoid
double counting of patients, patients from the study of
Giustetto et al who had been included in the article by Probst
et al were excluded from our original database. Therefore, in
Table 2, the total numbers of patients and events are lower
than those in our original article.12Results
Preliminary analysis of the largest studies
The 8 selected large studies and the characteristics of their
patients are listed in Table 3. The number of patients in these
8 studies1,7–13 ranged between 155 and 967. All studies
included patients with both spontaneous and drug-induced
type 1 ECG patterns. The composition of the various
populations was similar in terms of the prevalence of
spontaneous type 1 ECG pattern (with the exception of the
study by Brugada et al, Takagi et al, and Kamakura et al that
had a 71%–86% prevalence vs 45%–59% in other studies),in patients with and without ICD
ICD implanted/not implanted ICD-FVA SD (no ICD)
177/370 29/177 16/370
70/130 3/70 1/130
379/588 22/379 7/588
47/107 8/47 2/107
137/171 14/137 1/171
810/1366 76/810 27/1366
ts were also included in the multicenter study by Probst et al.11 The study by
he multicenter study by Delise et al.12
from Giustetto et al10 had been previously included in the article by Probst
robst et al11 were therefore excluded from our original database. Thus, the
article.
mias recorded by implantable cardioverter-deﬁbrillator; IQR ¼ interquartile
deﬁbrillator.
Figure 1 Event rates per 1000 patient-years of follow-up in the
cumulative analysis of articles listed in Table 2. ICD ¼ implantable
cardioverter-deﬁbrillator.
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up ranged from 26 to 40 months.
With regard to outcome, all studies considered total
events, calculated as the sum of ICD-FVA and SD occurring
in those without an ICD. Total events ranged from 2.6% to
8.2%. SD in all studies ranged from 0% to 1%, with the
exception of the study by Brugada et al,4 which reported a
value of 2.9%.
All 8 selected studies unanimously recognized sponta-
neous type 1 ECG pattern and syncope as risk factors. The
signiﬁcance of familial SD, however, was controversial.
Moreover, the prognostic value of a þEPS proved to be
highly controversial. Indeed, Brugada et al4 and Giustetto
et al10 suggested that it had a signiﬁcant prognostic value
while Eckardt et al7, Probst et al,11 and Priori et al13 denied
that it had any value. Delise et al12 suggested a prognostic
value only in combination with other risk factors.
While these conﬂicting results may be partially
explained by nonhomogeneous stimulation protocols, other
factors were probably at work. For example, in the
PRELUDE study,13 most events (9 of 14) occurred in
patients with –EPS. However, in 182 patients with –EPS,
major events occurred in 20% (8 of 39) of the patients with
an ICD and only in 0.6% (1 of 143) of those without an ICD
(P o .0001). Furthermore, in 126 patients with þEPS, all
events occurred in patients with ICD (5 of 98 vs 0 of 28;
P ¼ .58).
Other risk factors recently have been recognized in single
studies: QRS fragmentation,13,15 the occurrence/increase of
ST-segment elevation after exercise,16 and the presence of J
wave.20 However, these risk factors, except QRS fragmen-
tation in the PRELUDE study,13 were not analyzed in the
selected 8 largest studies.
Finally, both the studies by Brugada et al4 and by Delise
et al12 suggested that patients at the highest risk of events
were those with spontaneous type 1 ECG pattern and at least
2 adjunctive risk factors (syncope, þEPS, and familial SD).
Other studies did not analyze the prognostic signiﬁcance of
multiple risk factors and their combinations.Event rates in patients with and without ICD
We performed a cumulative analysis of 5 of the aforemen-
tioned 8 selected largest studies.4,9–11,16 The study by
Eckardt et al7 was excluded from this analysis because part
of their population was included in the multicenter study by
Probst et al.9 The study by Giustetto et al10 was also
excluded because part of their population was included both
in the multicenter study by Probst et al9 and in that by Delise
et al.12 The study of Takagi et al8 was also excluded because
part of their population was included in the multicenter study
of Kamakura et al.9
The ﬁnal analysis included 2176 patients, about one-third
of whom had an ICD and two-thirds did not (Table 3).
Event rates per 1000 patient-years of follow-up were 31.3
(25–39) and 6.5 (4–10) in patients with and without ICD,
respectively (P o .001; Figure 1).Prevalence of risk factors in patients with and
without ICD implantation in various studies
The prevalence of risk factors in patients with ICD was not
available from the studies by Brugada et al4 and Probst et al11
listed in Table 2. These data were available from Kamakura
et al,9 Delise et al,12 and partially from Priori et al.13 In
addition, the studies by Sacher et al17 and Sarkozy et al,18
which analyzed only patients with ICD in detail, were
selected (Table 1).
The prevalence of risk factors in patients without an ICD
was not available from all the studies listed in Table 2. No
data were available from the study by Probst et al,11 and only
partial data were available from those of Brugada et al4 and
Priori et al13 (Table 4).
On analyzing the characteristics of patients who had an
ICD (Table 1), the prevalence of classical risk factors was
65% for spontaneous type 1 ECG pattern, 39% for familial
SD, 45% for syncope, and 80% forþEPS. Overall, the mean
number of risk factors per patient was 2.3 (1.5 excluding
þEPS).
By contrast, on analyzing the prevalence of the same risk
factors in patients who had not undergone ICD implantation
(in studies in which these data were available; Table 4), a
spontaneous type 1 ECG pattern was present in 54%, familial
SD in 18%, syncope in 16%, and þEPS in 22%. Overall, the
mean number of risk factors was 1.1 (0.88 excludingþEPS).
The prevalence of risk factors was signiﬁcantly higher in
patients with ICD than in those without ICD: spontaneous
type 1 ECG pattern, 279 of 429 vs 183 of 340 (P ¼ .002);
familial SD, 169 of 429 vs 61 of 340 (P o .001); syncope,
192 of 429 vs 55 of 340 (Po .001);þEPS, 437 of 543 vs 98
of 442 (P o .001) (Figure 2).
Prognostic value of classical risk factors in studies
evaluating patients with ICD in detail
Five studies were selected9,12–14,17; these are listed in
Table 1. Two of the 5 speciﬁcally addressed the outcome
of patients with Brugada syndrome who had ICD.14,17 All 4
studies addressed the prognostic value of classical risk
Table 4 Prevalence of risk factors in patients without previous cardiac arrest who were not candidates for ICD
Study No. of patients* Type 1 ECG pattern Familial SD Syncope þEPS/EPS performed
Brugada et al4 370 (68) NA NA NA 25/68
Kamakura et al9 130 (64) 92/130 9/130 14/130 39/64
Delise et al12 210 (139) 92/210 52/210 41/210 6/139
Priori et al13 171 (171) NA NA NA 28/171
Total no. of cases 881 (442) 184/340 (54%) 61/340 (18%) 55/340 (16%) 98/442 (22%)
ECG ¼ electrocardiographic; þEPS ¼ positive electrophysiologic study; ICD ¼ implantable cardioverter-deﬁbrillator; SD ¼ sudden death.
*Patients who did not undergo implantation; the values in parentheses present patients without ICD who underwent EPS.
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with ICD was recruited. During follow-up, 51 (9%) patients
had ICD-FVA. Table 5 shows true-positive, false-positive,
true-negative, and false-negative results for each risk factor.
Best sensitivity was obtained by spontaneous type 1 ECG
pattern and þEPS (86% and 79%, respectively), although
their speciﬁcity was extremely low. All risk factors showed a
low PPV (ranging from 9% to 15%). All risk factors showed
a high NPV (ranging from 89% to 95%), the highest NPV
being observed for a spontaneous type 1 ECG pattern.Prognostic value of classical risk factors in studies
evaluating patients without ICD in detail
Six of the 8 largest studies listed in Table 1 prospectively
reported cases of SD4,8–10,12 and 1 of resuscitated cardiac
arrest.11 However, only in 3 studies10,12,13 could the preva-
lence of risk factors be established in patients with these
events. These studies recruited 5 cases of SD in 491 (1%)
patients. A spontaneous type 1 ECG pattern was present in 5
of 5, familial SD in 1 of 5, and syncope in 0 of 5. EPS was
unavailable in 4 and negative in 1.
From these data, we can deduce a sensitivity of 100% for
spontaneous type 1 ECG pattern, 20% for familial SD, and
0% for syncope. Furthermore, we can deduce a PPV of 0%
for syncope and of 0%–2% for familial SD.Figure 2 Prevalence of risk factors in patients with and without ICD.
Patients with ICD had a mean of 2.3 risk factors while those without an ICD
had a mean of 1.1 risk factors. þEPS ¼ positive electrophysiology study;
Fam SD ¼ familial sudden death; ICD ¼ implantable cardioverter-
deﬁbrillator; type 1 ¼ spontaneous type 1 electrocardiographic pattern.A cumulative analysis including speciﬁcity and NPV was
not possible, as no study (except ours10) reported the
characteristics of patients without ICD separately. All these
data, however, should be considered with caution owing to
the small number of patients.Discussion
Patients with type 1 Brugada ECG pattern may suffer SD.
Correct risk stratiﬁcation in these patients is therefore
important both to prevent SD and to avoid unnecessary
ICD implantation. Indeed, patients with ICDmay suffer from
several complications (infections, catheter damage, and
inappropriate discharge) that are deleterious, especially in
young patients.
All studies that have addressed the issue of risk strat-
iﬁcation in patients with type 1 Brugada ECG pattern1–16 are
registry-based population studies. There have been no
randomized studies allocating patients with risk factors to
ICD or no-ICD groups. Furthermore, all prospective studies
that have tried to stratify risk in patients with type 1 Brugada
ECG pattern have evaluated a combined end point con-
stituted by FVA-ICD and SD in patients without ICD. ICD-
FVA are only a surrogate of SD, as nonlethal arrhythmias
may be counted. Therefore, the real incidence of SD in
patients with type 1 Brugada ECG pattern is uncertain.
Moreover, the prognostic value of single risk factors with
regard to ICD-FVA and SD in patients without ICD is also
uncertain. Finally, as ICD-FVA and SD have a low
incidence, most studies have recruited a relatively small
number of cases.
In the present study, we analyzed the largest available
studies that have tried to stratify risk in patients with type 1Table 5 Sensitivity, speciﬁcity, PPV, and NPV of the various risk
factors according to the data from the 5 studies listed in Table 3
(Sacher et al17, Sarkozy et al14, Kamakura,9 Delise et al,12 and Priori
et al13)
Parameter
Spontaneous type
1 ECG pattern Familial SD Syncope þEPS
Sensitivity 86% 39% 61% 79%
Speciﬁcity 36% 61% 52% 21%
PPV 15% 11% 14% 9%
NPV 95% 89% 91% 90%
ECG ¼ electrocardiographic; þEPS ¼ positive electrophysiology study;
PPV ¼ positive predictive value; NPV ¼ negative predictive value; SD ¼
sudden death.
257Delise et al Sudden Death in Brugada Syndrome: A Cumulative AnalysisBrugada ECG pattern. A preliminary analysis of the 8 largest
studies4,7–13 shows that most events occur in patients with
ICD while SD in patients without ICD is rare over a follow-
up ranging from 20 to 40 months. An exception is constituted
by the study by Brugada et al4 (2.9% SD rate), which
probably recruited patients at the highest risk.
Our cumulative analysis of 2176 patients revealed that the
incidence of events (ICD-FVA) in patients with an ICD
proved to be over 5 times higher than that of SD or aborted
SD in patients without an ICD (Table 2 and Figure 1). This
conclusion emerges from 5 studies4,9,11–13 that were homo-
geneous in terms of the prevalence of classical risk factors,
including þEPS, and the proportion of patients in whom
ICD were implanted (about one-third; Table 2).
We also made a cumulative analysis of studies that
evaluated the prognostic value of risk factors separately in
patients with and without ICD. With regard to patients with
an ICD, 5 studies were selected9,12–14,17 that recruited a
population of 566 patients. An analysis of these patients
revealed the limited clinical value of any single risk factor in
predicting ICD-FVA. Indeed, no classic risk factor proved to
be a prognostic gold standard. Sensitivity ranged from 39%
(familial SD) to 86% (spontaneous type 1 pattern). Speciﬁc-
ity was extremely low, ranging from 21% to 61%. In
addition, all risk factors displayed a low PPV, ranging from
9% (þEPS) to 15% (spontaneous type 1 ECG pattern). By
contrast, their NPV was high (89%–95%), with type 1
spontaneous ECG pattern displaying the highest value.
For patients without an ICD, only in 3 studies10,12,13
could the prevalence of risk factors be established in patients
with these events. These studies recorded 5 cases of SD in
491 patients. A spontaneous type 1 ECG pattern was present
in 5 of 5, familial SD in 1 of 5, syncope in 0 of 5, and EPS
was unavailable in 4 and negative in 1. Thus, few data on the
prediction of SD are available and, paradoxically, with the
exception of spontaneous type 1 ECG pattern, the risk factors
considered seem to be of little use.
Other new risk factors have recently been proposed—
QRS fragmentation,13,15 the occurrence/increase of
ST-segment elevation after effort,16 and the presence of
J wave20—which should have interesting clinical applica-
tion. However, most of these studies15,16,20 in which these
risk factors have been investigated were not part of our
cumulative analysis, as they did not satisfy our inclusion
criteria.
The main ﬁnding to emerge from our study is that in
patients with type 1 Brugada ECG pattern without previous
cardiac arrest, most events occur in patients with ICD while
SD is rare in those without ICD. This raises the question
“Why?” Two hypotheses can be advanced:
1. The ﬁrst hypothesis is that, in clinical practice,
candidates for ICD implantation are well stratiﬁed. This
hypothesis is supported by the modality of selection adopted
by all authors. Indeed, our cumulative analysis of available
studies showed that patients who had undergone ICD
implantation had a mean of more than 2 risk factors, the
most common being þEPS (80%), followed by spontaneoustype 1 ECG pattern (65%), syncope (45%), and familial SD
(39%). By contrast, patients who had not undergone implan-
tation had a mean of 1.1 risk factor; speciﬁcally, only 22%
hadþEPS, 54% type 1 ECG pattern, 16% syncope, and 18%
familial SD. These data demonstrate that, in clinical practice,
when the decision to implant an ICD was made, a poly-
parametric approach was adopted.
2. The second hypothesis is that the number of events
recorded by ICD overestimates the risk of SD because
potentially self-terminating and nonlethal arrhythmias may
be counted.21 There is no proof of this assumption; indeed, in
patients without an ICD, we have no data on the incidence of
self-terminating arrhythmias, regardless of whether asymp-
tomatic or causing presyncope or syncope but not SD.
Nevertheless, this hypothesis is intriguing and could explain
why in the PRELUDE study,13 in 126 patients withþEPS all
events occurred in patients with ICD (5 of 98 vs 0 of 28; P¼
.58) while in 182 patients with –EPS major events occurred
in 20% (8 of 39) of the patients with ICD and only in 0.6%
(1 of 143) of those without an ICD (Po .0001). Moreover, if
this hypothesis is true, the high prevalence of events and of
þEPS in patients with ICD could mean that EPS predicts
ICD-FVA that may not necessarily be lethal.Study limitations
This study is not a multicenter prospective study, but a
retrospective cumulative analysis of the largest published
studies.
The data obtained from our analysis were checked by the
respective authors who provided some data that were
unavailable in their original articles. However, we did not
obtain all original data. Consequently, we were unable to
make further analyses that would have been interesting.Conclusions
The available data show that in patients with type 1 Brugada
ECG pattern and without previous cardiac arrest, we
currently have an acceptable ability to predict ICD-FVA
but have insufﬁcient data to predict SD. In any case, all these
data suggest that SD is rare in Brugada syndrome, partic-
ularly in patients without ICD, who account for two-thirds of
the total population.
In addition, ICD-FVA are rare in patients without
spontaneous type 1 ECG (ie, with only drug-induced type 1)
pattern, such as in those who are asymptomatic, those
without familial SD, and those with –EPS, thanks to the
extremely high NPV of all these factors.
Consequently, an extensive indication for ICD implanta-
tion should be avoided in patients without risk factors or with
only single risk factors (including þEPS). By contrast, ICD
implantation should be proposed in the presence of multiple
risk factors (syncope, familial SD, andþEPS), particularly in
patients with spontaneous type 1 ECG pattern, as suggested
by Brugada et al4 in 2003, by Antzelevitch et al6 in 2005, and
by Delise et al12 in 2011.
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